Literature DB >> 21810614

The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.

Michael Reiser1, Andreas Wieland, Bodo Plachter, Thomas Mertens, Jochen Greiner, Reinhold Schirmbeck.   

Abstract

Immunodominance hierarchies operating in immune responses to viral Ags limit the diversity of the elicited CD8 T cell responses. We evaluated in I-A(b+)/A2-HHD-II and HLA-DR1(+)/A2-DR1 mice the HLA-A*0201-restricted, multispecific CD8 T cell responses to the human CMV tegument phosphoprotein pp65 (pp65) Ag. Vaccination of mice with pp65-encoding DNA elicited high IFN-γ(+) CD8 T cell frequencies to the pp65(495-503)/(e6) epitope and low responses to the pp65(320-328)/(e3) and pp65(522-530)/(e8) epitopes. Abrogation of the e6-specific immunity efficiently enhanced e3- and e8-specific T cell responses by a pp65(Δ501-503) DNA vaccine. The immunodominant e6-specific (but not the e3- and e8-specific) CD8 T cell response critically depends on CD4 T cell help. Injection of monospecific DNA- or peptide-based vaccines encoding the e3 or e8 (but not the e6) epitope into mice elicited CD8 T cells. Codelivering the antigenic peptides with different heterologous CD4 T cell helper epitopes enhanced e6-specific (but not e3- or e8-specific) CD8 T cell responses. Similarly, homologous CD4 T cell help, located within an overlapping (nested) pp65(487-503) domain, facilitated induction of e6-specific CD8 T cell responses by peptide-based vaccination. The position of the e6 epitope within this nested domain is not critical to induce the immunodominant, e6-specific CD8 T cell response to the pp65 Ag. Distant CD4 T cell epitope(s) can thus provide efficient help for establishing pp65-e6 immunodominance in vaccinated mice. These results have practical implications for the design of new T cell-stimulating vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810614     DOI: 10.4049/jimmunol.1002512

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.

Authors:  Corinna La Rosa; Jeff Longmate; Simon F Lacey; Teodora Kaltcheva; Rahul Sharan; Denise Marsano; Peter Kwon; Jennifer Drake; Brenda Williams; Sharon Denison; Suenell Broyer; Larry Couture; Ryotaro Nakamura; Sanjeet Dadwal; Morris I Kelsey; Arthur M Krieg; Don J Diamond; John A Zaia
Journal:  J Infect Dis       Date:  2012-03-07       Impact factor: 5.226

2.  Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation.

Authors:  Yang Zeng; Tongtong Gao; Guangyu Zhao; Yuting Jiang; Yi Yang; Hong Yu; Zhihua Kou; Yuchun Lone; Shihui Sun; Yusen Zhou
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 3.  Cross-presentation of IgG-containing immune complexes.

Authors:  Kristi Baker; Timo Rath; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Cell Mol Life Sci       Date:  2012-07-31       Impact factor: 9.261

4.  The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools.

Authors:  Satwinder Kaur Singh; Maaike Meyering; Tamara H Ramwadhdoebe; Linda F M Stynenbosch; Anke Redeker; Peter J K Kuppen; Cornelis J M Melief; Marij J P Welters; Sjoerd H van der Burg
Journal:  Cancer Immunol Immunother       Date:  2012-04-11       Impact factor: 6.968

5.  The TLR2 Binding Neisserial Porin PorB Enhances Antigen Presenting Cell Trafficking and Cross-presentation.

Authors:  Michael L Reiser; Munir M Mosaheb; Christina Lisk; Andrew Platt; Lee M Wetzler
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

Review 6.  Advances in Transgenic Mouse Models to Study Infections by Human Pathogenic Viruses.

Authors:  Dörthe Masemann; Stephan Ludwig; Yvonne Boergeling
Journal:  Int J Mol Sci       Date:  2020-12-05       Impact factor: 5.923

Review 7.  Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse.

Authors:  Janice J Endsley; Matthew B Huante; Kubra F Naqvi; Benjamin B Gelman; Mark A Endsley
Journal:  Retrovirology       Date:  2021-06-16       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.